Literature DB >> 28663227

National Healthcare Safety Network (NHSN) Dialysis Event Surveillance Report for 2014.

Duc B Nguyen1, Alicia Shugart2, Christi Lines2, Ami B Shah2, Jonathan Edwards2, Daniel Pollock2, Dawn Sievert2, Priti R Patel2.   

Abstract

BACKGROUND AND OBJECTIVES: Persons receiving outpatient hemodialysis are at risk for bloodstream and vascular access infections. The Centers for Disease Control and Prevention conducts surveillance for these infections through the National Healthcare Safety Network. We summarize 2014 data submitted to National Healthcare Safety Network Dialysis Event Surveillance. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Dialysis facilities report three types of dialysis events (bloodstream infections; intravenous antimicrobial starts; and pus, redness, or increased swelling at the hemodialysis vascular access site). Denominator data consist of the number of hemodialysis outpatients treated at the facility during the first 2 working days of each month. We calculated dialysis event rates stratified by vascular access type (e.g., arteriovenous fistula, arteriovenous graft, or central venous catheter) and standardized infection ratios (comparing individual facility observed with predicted numbers of infections) for bloodstream infections. We described pathogens identified among bloodstream infections.
RESULTS: A total of 6005 outpatient hemodialysis facilities reported dialysis event data for 2014 to the National Healthcare Safety Network. These facilities reported 160,971 dialysis events, including 29,516 bloodstream infections, 149,722 intravenous antimicrobial starts, and 38,310 pus, redness, or increased swelling at the hemodialysis vascular access site events; 22,576 (76.5%) bloodstream infections were considered vascular access related. Most bloodstream infections (63.0%) and access-related bloodstream infections (69.8%) occurred in patients with a central venous catheter. The rate of bloodstream infections per 100 patient-months was 0.64 (0.26 for arteriovenous fistula, 0.39 for arteriovenous graft, and 2.16 for central venous catheter). Other dialysis event rates were also highest among patients with a central venous catheter. Facility bloodstream infection standardized infection ratio distribution was positively skewed with a median of 0.84. Staphylococcus aureus was the most commonly isolated bloodstream infection pathogen (30.6%), and 39.5% of S. aureus isolates tested were resistant to methicillin.
CONCLUSIONS: The 2014 National Healthcare Safety Network Dialysis Event data represent nearly all United States outpatient dialysis facilities. Rates of infection and other dialysis events were highest among patients with a central venous catheter compared with other vascular access types. Surveillance data can help define the epidemiology of important infections in this patient population.
Copyright © 2017 by the American Society of Nephrology.

Entities:  

Keywords:  dialysis; infection; surveillance

Mesh:

Substances:

Year:  2017        PMID: 28663227      PMCID: PMC5498356          DOI: 10.2215/CJN.11411116

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  25 in total

1.  Bacterial infections in hemodialysis patients: pathogenesis and prevention.

Authors:  Bertrand L Jaber
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

2.  EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients.

Authors:  B Hoen; A Paul-Dauphin; D Hestin; M Kessler
Journal:  J Am Soc Nephrol       Date:  1998-05       Impact factor: 10.121

3.  Dialysis Event Surveillance Report: National Healthcare Safety Network data summary, January 2007 through April 2011.

Authors:  Priti R Patel; Alicia Shugart; Chukwuma Mbaeyi; Ann Goding Sauer; Anna Melville; Duc B Nguyen; Alexander J Kallen
Journal:  Am J Infect Control       Date:  2016-03-31       Impact factor: 2.918

4.  Description of a new surveillance system for bloodstream and vascular access infections in outpatient hemodialysis centers.

Authors:  J I Tokars
Journal:  Semin Dial       Date:  2000 Mar-Apr       Impact factor: 3.455

5.  Epidemiology, surveillance, and prevention of bloodstream infections in hemodialysis patients.

Authors:  Priti R Patel; Alexander J Kallen; Matthew J Arduino
Journal:  Am J Kidney Dis       Date:  2010-06-15       Impact factor: 8.860

6.  Recommendations for preventing transmission of infections among chronic hemodialysis patients.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2001-04-27

7.  Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.

Authors:  Kevin E Chan; H Shaw Warren; Ravi I Thadhani; David J R Steele; Jeffrey L Hymes; Franklin W Maddux; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 10.121

Review 8.  Infection with antimicrobial-resistant microorganisms in dialysis patients.

Authors:  Jeffrey S Berns
Journal:  Semin Dial       Date:  2003 Jan-Feb       Impact factor: 3.455

9.  Invasive methicillin-resistant Staphylococcus aureus infections among patients on chronic dialysis in the United States, 2005-2011.

Authors:  Duc B Nguyen; Fernanda C Lessa; Ruth Belflower; Yi Mu; Matthew Wise; Joelle Nadle; Wendy M Bamberg; Susan Petit; Susan M Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; Jamie Thompson; William Schaffner; Priti R Patel
Journal:  Clin Infect Dis       Date:  2013-08-19       Impact factor: 9.079

10.  Public reporting of health care-associated surveillance data: recommendations from the healthcare infection control practices advisory committee.

Authors:  Thomas R Talbot; Dale W Bratzler; Ruth M Carrico; Daniel J Diekema; Mary K Hayden; Susan S Huang; Deborah S Yokoe; Neil O Fishman
Journal:  Ann Intern Med       Date:  2013-11-05       Impact factor: 25.391

View more
  34 in total

1.  Infection Monitoring in Dialysis Units: A Plea for "Cleaner" Data.

Authors:  Dana C Miskulin; Ambreen Gul
Journal:  Clin J Am Soc Nephrol       Date:  2017-06-29       Impact factor: 8.237

2.  Two-Year Observational Study of Bloodstream Infection Rates in Hemodialysis Facility Patients with and without Catheters.

Authors:  Robert S Brown; Kristin Brickel; Roger B Davis
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-07       Impact factor: 8.237

3.  Long Overdue Need to Reduce Infections with Hemodialysis.

Authors:  Alan S Kliger; Allan J Collins
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-03       Impact factor: 8.237

4.  Targeting Zero Infections in Dialysis: New Devices, Yes, but also Guidelines, Checklists, and a Culture of Safety.

Authors:  Alan S Kliger
Journal:  J Am Soc Nephrol       Date:  2018-03-05       Impact factor: 10.121

Review 5.  Trends in Community Versus Health Care-Acquired Methicillin-Resistant Staphylococcus aureus Infections.

Authors:  David P Calfee
Journal:  Curr Infect Dis Rep       Date:  2017-11-03       Impact factor: 3.725

6.  Systems Thinking and Leadership: How Nephrologists Can Transform Dialysis Safety to Prevent Infections.

Authors:  Leslie P Wong
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-22       Impact factor: 8.237

Review 7.  Antimicrobial resistance in nephrology.

Authors:  Tina Z Wang; Rosy Priya L Kodiyanplakkal; David P Calfee
Journal:  Nat Rev Nephrol       Date:  2019-08       Impact factor: 28.314

8.  The Making Dialysis Safer for Patients Coalition: A New Partnership to Prevent Hemodialysis-Related Infections.

Authors:  Priti R Patel; Kristin Brinsley-Rainisch
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-09       Impact factor: 8.237

9.  Tunneled hemodialysis catheter care practices and blood stream infection rate in children: results from the SCOPE collaborative.

Authors:  Olivera Marsenic; Jonathan Rodean; Troy Richardson; Sarah Swartz; Donna Claes; J Christopher Day; Bradley Warady; Alicia Neu
Journal:  Pediatr Nephrol       Date:  2019-10-25       Impact factor: 3.714

10.  Cluster-Randomized Trial of Devices to Prevent Catheter-Related Bloodstream Infection.

Authors:  Steven M Brunelli; David B Van Wyck; Levi Njord; Robert J Ziebol; Laurie E Lynch; Douglas P Killion
Journal:  J Am Soc Nephrol       Date:  2018-02-22       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.